Author details

Full Name

Arthur Y Kim

Affiliation

ORCID

Career Start Year

1994

Papers

182

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36972796	Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis.	J Hepatol	2024
37496604	Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy-Boston, Massachusetts, 2016-2021.		2023
38023556	Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study.		2023
36910479	Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial.	Front Med (Lausanne)	2023
36969241	Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative.	Front Immunol	2023
37150144	Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs.		2023
36508742	Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System : A Population-Based Cohort Study.		2023
37467042	Reinfection incidence and risk among people treated for recent hepatitis C virus infection.		2023
36948600	Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure.		2023
36880897	The experience of re-infection among people who inject drugs successfully treated for hepatitis C.		2023
37352211	Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design.	PLoS One	2023
34752147	Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study.	J Clin Oncol	2022
36370741	Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial.	Lancet Gastroenterol Hepatol	2022
35511194	Clearance of Hepatitis B e Antigen in Untreated Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-analysis.	Journal of Infectious Diseases	2022
35817068	Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B.	Lancet HIV,The	2022
35734084	Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system.		2022
36129038	Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection.	J Am Heart Assoc	2022
35729038	Treatment for hepatitis C virus with direct acting antiviral agents: Perspectives and treatment experiences of people who inject drugs.	Journal of Substance Abuse Treatment	2022
36438619	Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System.	Open Forum Infectious Diseases	2022
35716846	Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen infection.	Journal of Hepatology	2022
34334359	Screening for Hepatitis B Virus Prior to Initiating Tocilizumab and Tofacitinib in Patients With Rheumatic Diseases: A Cross-sectional Study.	J Rheumatol	2022
34905514	Peripheral blood iNKT cell activation correlates with liver damage during acute hepatitis C.	JCI Insight	2022
35090584	Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQÎ²1.	Am J Hum Genet	2022
34424310	Hepatitis B Vaccination in People Living With HIV-If at First You Don't Succeed, Try Again.	JAMA network open	2021
32415860	Liver Biochemistries in Hospitalized Patients With COVID-19.	Hepatology	2021
34159495	Preventing Infectious Complications of Immunomodulation in COVID-19 in Foreign-Born Patients.	J Immigr Minor Health	2021
34313704	Screening for Hepatitis C Virus.	JAMA - Journal of the American Medical Association	2021
34312547	Epigenetic scars of CD8<sup>+</sup> T cell exhaustion persist after cure of chronic infection in humans.	Nat Immunol	2021
34312544	Differentiation of exhausted CD8<sup>+</sup> T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory.	Nat Immunol	2021
33496769	Update on Hepatitis A Management-Reply.	JAMA - Journal of the American Medical Association	2021
33035308	Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2: What Goes Around May Come Back Around.	Clinical Infectious Diseases	2021
33119750	A Multiancestry Sex-Stratified Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.	J Infect Dis	2021
32732241	The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infection: a case series.	Ann Rheum Dis	2021
33216852	Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions.	Clinical Infectious Diseases	2021
34553511	Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19.	Hepatology Communications	2021
30816419	Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection.	Clinical Infectious Diseases	2020
31904582	Hepatitis C virus-specific CD4+ T cell phenotype and function in different infection outcomes.	Journal of Clinical Investigation	2020
32315424	Desperate Times Call for Temperate Measures: Practicing Infectious Diseases During a Novel Pandemic.	Journal of Infectious Diseases	2020
31887236	Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning.	Am J Transplant	2020
32350928	Rethinking the role of hydroxychloroquine in the treatment of COVID-19.	FASEB J	2020
32766600	Temporal and Spatial Heterogeneity of Host Response to SARS-CoV-2 Pulmonary Infection.	medRxiv	2020
33085857	Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.	N Engl J Med	2020
33298930	Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection.	Nat Commun	2020
32628251	Management of Hepatitis A in 2020-2021.	JAMA - Journal of the American Medical Association	2020
32513665	Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19.	Journal of the American Society of Nephrology : JASN	2020
33230236	Correction: Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection.	Genes Immun	2020
33116245	Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection.	Genes Immun	2020
32604138	Disproportionate burden of coronavirus disease 2019 among racial minorities and those in congregate settings among a large cohort of people with HIV.	AIDS	2020
31204102	Fc Glycan-Mediated Regulation of Placental Antibody Transfer.	Cell	2019
31890461	Testing for Hepatitis C in Pregnancy: the Time has Come for Routine Rather than Risk-based.	Current Hepatitis Reports	2019